2026 ASH®
Annual Meeting & Exposition December 12-15, 2026 ▪ New Orleans, Louisiana

Paper Details

Abstracts, authors, affiliations, and disclosures.

Monday, December 14, 2026
04:30 p.m. - 06:00 p.m.
MCCNO - 291-292
Technology and Procedures, Assays, Imaging, Omics Technologies, Bioinformatics, Blood Banking, Cell Expansion, Gene Editing, Profiling, Biological Processes, Genomics, Hematopoiesis, Metabolism, Molecular Biology, Diseases, Genetic Disorders, Metabolic Disorders, Research, Fundamental Science, Translational Research, Study Population, Human, Adult
PAPER

980 Loss of PINK1 disrupts mitochondrial homeostasis and mitophagy during terminal erythroid maturation, enhancing enucleation and red blood cell production

Anagha Mira Menon, Jiajing Qiu, PhD2, Mary Slavinsky, N/A3, Nuo Sun4, Marine Luka5, Mickaël M Ménager, PhD6, Maxime Batignes7, Saghi Ghaffari Jr, MD PhD8
1 Icahn School of Medicine at Mount Sinai, New York, New York, United States
2 Icahn School of Medicine at Mount Sinai, New York, New York, United States
3 Icahn School of Medicine at Mount Sinai, New York, New York, United States
4 The Ohio State University Wexner Medical Center, Columbus, Ohio, United States
5 Imagine Institute, INSERM, Paris, France
6 Imagine Institute, INSERM, Paris, France
7 Imagine Institute, INSERM, Paris, France
8 Icahn School of Medicine at Mount Sinai, New York, New York, United States, Icahn School of Medicine at Mount Sinai, New York, New York, United States

Red blood cell (RBC) formation involves an extensive cellular remodeling and culminates in enucleation – the extrusion of the nucleus. However, terminal stages of erythroid maturation during which this rate-limiting process of enucleation occurs (at the orthochromatic erythroblast stage) remain understudied. Our laboratory previously found that mitochondrial aggregation behind the nucleus is essential for erythroblast enucleation in mice, indicating that mitochondria play an active role in terminal erythroid maturation and enucleation prior to their elimination by mitophagy, the selective autophagic removal of mitochondria. Although PINK1 (PTEN-induced Kinase 1) regulation of PARKIN is the main regulator of mitophagy, the physiological role of PINK1 in terminal erythroid maturation is poorly understood. Through flow cytometry analysis of terminal erythroblasts using cell surface markers TER119 and CD44, we found that Pink1-/- mice produce significantly more RBCs than Wild Type (WT) mice, consistent with an erythrocytosis phenotype. To assess enucleation, we isolated Pink1-/- and WT orthochromatic erythroblasts, stained them with the live-cell nuclear dye DRAQ5 and quantified the percentage of DRAQ5 negative (enucleated) cells by flow cytometry in an 8-hour ex vivo culture. Pink1-/- exhibited significantly higher rates of enucleation compared to WT erythroblasts. Given PINK1’s known role in mitochondrial quality control, we evaluated mitochondrial content in terminally maturing Pink1-/- versus WT erythroblasts using high resolution confocal microscopy and immunofluorescence staining for outer mitochondrial membrane protein TOM20. We found that TOM20 expression is significantly higher in Pink1-/- orthochromatic erythroblasts, indicating mitochondrial retention which may contribute to the enhanced enucleation phenotype observed in Pink1-/- erythroblasts. Mitochondria are dynamic organelles that continuously undergo cycles of fission and fusion. Using high resolution confocal microscopy, we quantified mitochondrial (1) morphology, namely size and fragmentation, and (2) localization of fission regulator DRP1 (Dynamin-Related Protein 1), an indicator of mitochondrial fission. We found that Pink1-/- polychromatophilic and orthochromatic erythroblasts exhibited significantly increased fusion with reduced mitochondrial DRP1 expression. This is consistent with mitochondrial dysfunction potentially triggering a compensatory increase in fusion to facilitate exchange of mitochondrial DNA, electron transport chain components, and metabolic intermediates. We further characterized mitochondrial function using Seahorse Extracellular Flux assay and found that mitochondria in Pink1-/- maturing erythroblasts exhibited significantly lower basal respiration and oxygen consumption rates relative to control. Pink1-/- terminal erythroblasts also have significantly elevated reactive oxidative species levels, altogether suggesting Pink1-/- maturing erythroblasts accumulate dysfunctional mitochondria; thus PINK1 may be a physiological regulator of mitophagy during terminal erythroid maturation. To evaluate this, we obtained mitochondrial Keima (mtKeima) mitophagy reporter mice that we backcrossed with Pink1-/- mice, enabling us to measure in vivo mitophagy rates in Pink1-/- mtKeima versus WT mtKeima mice by quantifying acidic to neutral fluorescent signal ratio via confocal microscopy in erythroblasts. We first confirmed by flow cytometry that terminal erythroid maturation profiles are identical in mtKeima and WT mice. Confocal microscopy analyses showed that in vivo rates of mitophagy were significantly decreased in Pink1-/- mtKeima versus WT mtKeima terminal erythroblasts, indicating a mitophagy defect. Our ongoing transcriptomic analysis of Pink1-/- versus WT terminal erythroblasts using single cell RNA sequencing will provide further insight into disrupted mitochondrial metabolic pathways, chromatin modulators and epigenetic regulators. Overall, our work identifies PINK1 as a physiological regulator of mitochondrial quality and mitophagy during terminal erythropoiesis, and its loss disrupts mitochondrial homeostasis leading to enhanced enucleation and erythrocytosis. These findings provide new insights into the role of mitochondrial dynamics in erythropoiesis, and may have important clinical implications for benign erythrocytosis, as well as for strategies aimed at improving the in vitro production of RBCs.

Anagha Mira Menon: No relevant conflicts of interest to declare.